USPTO 2015–2025 USPTO PatentsView US Corporation

Alfred E. Mann Institute FOR Biomedical Engineering AT THE University OF Southern California

Q: Where does Alfred E. Mann Institute FOR Biomedical Engineering AT THE University OF Southern California rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Alfred E. Mann Institute FOR Biomedical Engineering AT THE University OF Southern California ranks #25,696 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: How is the Alfred E. Mann Institute FOR Biomedical Engineering AT THE University OF Southern California patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 10 granted patents across 10 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Alfred ranks #25,696 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 10 technology areas.

#25,696
of 49,997 US assignees by volume: Top 22%
by Innovation Score (46.0/100): 22.0
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25696 · US Corporation #25,696 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #25,696/49,997
PHOTO-FINISH Albaad Massuot Yitzhak
CPC-FOCUS A61B · 10 areas
INNOV-PAR 46.0/100
CLAIMS-DENSE 22.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Albaad Massuot Yitzhak Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Alfred’s 46.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (18%) Velocity 13.3 pts (29%) Breadth 11.2 pts (24%) Claim depth 13.2 pts (29%)

Qualcomm Incorporated · highest

85
Alfred E Mann… · this assignee

46
3D Lighting… · lowest

7

What this shows Alfred's Innovation Score is 46.0/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Alfred?

Each dot is one of Alfred’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Alfred’s own 22.0 claims/patent is ABOVE the 16.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Alfred vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Alfred's grants concentrate

Alfred E. Mann Institute FOR Biomedical Engineering AT THE University OF Southern California is a focused PatentsView assignee: 10 CPC subclasses with 40% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2016. By volume, Alfred sits between Albaad Massuot Yitzhak Ltd and Allied Moulded Products, Inc..

Alfred's three-year grant acceleration

Alfred E. Mann Institute FOR Biomedical Engineering AT THE University OF Southern California shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Albaad Massuot Yi…

10
ALC Holdings

10
Alfa Wassermann

10
Alfdex AB

10
Alfred-wegener-in…

10
Alken

10
Allen-vanguard

10
Allied Moulded Pr…

10
Alfred E Mann Ins… ◀

10

What this shows Alfred holds 10 patents at rank #25,666, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Alfred

By rank, the assignees closest to #25,666 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Alfred's primary technology class.

Alfred's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 22% higher than 78% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Alfred E. Mann Institute FOR Biomedical Engineering AT THE University OF Southern California patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	20.0%
2016	1	10.0%
2018	1	10.0%
2020	1	10.0%
2021	1	10.0%
2022	2	20.0%
2023	2	20.0%

Which technologies does Alfred E. Mann Institute FOR Biomedical Engineering AT THE University OF Southern California patent most?

A61B - DIAGNOSIS; SURGERY; Identification 4

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 4

C25D - Processes FOR THE Electrolytic OR Electrophoretic Production OF COATINGS; ELECTROFORMING; Apparatus Therefor 3

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

C08L - Compositions OF Macromolecular Compounds 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Alfred E. Mann Institute FOR Biomedical Engineering AT THE University OF Southern California's patent record in context - here's where to go next.

Alfred E. Mann Institute FOR Biomedical Engineering AT THE University OF Southern California's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 40% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #25,696 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Alfred E. Mann Institute FOR Biomedical Engineering AT THE University OF Southern California against Albaad Massuot Yitzhak Ltd, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.